Patent details

Basic Information

Publication number:

EP2301930

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101855286

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Derivatives of hexahydrobenzofuranone useful for the treatment of (inter alia) auto-immune or inflammatory disorders

French Title of Invention:

Dérivés der hexaxydrobenzofuranone utiles dans le traitement (de entre autres) maladies auto-immunes ou inflammatoires

German Title of Invention:

Für Behandlung von unter anderem Autoimmun- oder entzündlichen Erkrankungen geeignete Derivate von Hexahydrobezofuranon

SPC Number:

Dates

Filing date:

13/06/2001

Grant date:

06/01/2016

EP Publication Date:

06/01/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/03/2011

EP B1 Publication Date:

06/01/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/06/2016

Expiration date:

13/06/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/06/2001

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

Chelliah Marriappan

Address:

United States (US)

2

Name:

Xia Yan

Address:

United States (US)

3

Name:

Cackalamannil Samuel

Address:

United States (US)

Priority

Priority Number:

211724 P

Priority Date:

15/06/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 405/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages